Evidence map›Paper›PMID 30122998›Full record

ArticleCancer management and research2018

Biological and clinical influences of

Xinrui Yang, Jinlong Shi, Xinpei Zhang, Gaoqi Zhang, Jilei Zhang, Siyuan Yang, Jing Wang, Xiaoyan Ke, Lin Fu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer management and research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Impact ofTurkish journal of haematology : official journal of Turkish Society of Haematology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xinrui YangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Jinlong ShiDepartment of Biomedical Engineering, Chinese PLA General Hospital, Beijing 100853, China.
Xinpei ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Gaoqi ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Jilei ZhangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Siyuan YangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Jing WangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Xiaoyan KeDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Lin FuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China, fulin022@126.com.
Peking University · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePATIENTS AND

methodsWe screened The Cancer Genome Atlas (TCGA) database and found 51 AML patients with

resultsIn all,

conclusionOur study found that

Indexed as

AMLDNA methyltransferases 3Anext-generation sequencingnucleophosmin 1prognosis

Identifiers

PMID30122998
PMCPMC6086113
OpenAlexW2887710126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.